NYSEAMERICAN:ELMDElectromed Stock Price, Forecast & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Electromed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Electromed.

Electromed is scheduled to release its next quarterly earnings announcement on Tuesday, August 25th 2020. View our earnings forecast for Electromed.

Electromed, Inc. (NYSEAMERICAN:ELMD) released its earnings results on Tuesday, May, 12th. The medical equipment provider reported $0.07 EPS for the quarter, topping the Zacks' consensus estimate of $0.06 by $0.01. The medical equipment provider had revenue of $8.74 million for the quarter. View Electromed's earnings history.

1 brokerages have issued 12 month price targets for Electromed's shares. Their forecasts range from $12.00 to $12.00. On average, they anticipate Electromed's stock price to reach $12.00 in the next year. This suggests that the stock has a possible downside of 16.8%. View analysts' price targets for Electromed.

News stories about ELMD stock have been trending somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Electromed earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutElectromed.

Electromed saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 75,900 shares, an increase of 16.6% from the April 30th total of 65,100 shares. Based on an average trading volume of 169,000 shares, the short-interest ratio is presently 0.4 days. Currently, 1.2% of the company's stock are short sold. View Electromed's Current Options Chain.

Some companies that are related to Electromed include Avacta Group (AVCT), Creo Medical Group (CREO), Hamilton Thorne (HTL), Imricor Med SYS Cdi 1:1 US Person Prohibited Excluding QIB (IMR), Medica Group (MGP), Cyclopharm (CYC), Patient Home Monitoring (PTQ), Advanced Oncotherapy (AVO), Somnomed (SOM), Resonance Health (RHT), Kromek Group (KMK), REVA Medical (RVA), Total Brain (TTB), EMvision Medical Devices (EMV) and MRI Interventions (MRIC). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Electromed investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), TransEnterix (TRXC), Novavax (NVAX), AbbVie (ABBV), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Ampio Pharmaceuticals (AMPE), Energy Transfer LP Unit (ET) and Inovio Pharmaceuticals (INO).

Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."

Electromed's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Teton Advisors Inc. (1.48%), Essex Investment Management Co. LLC (1.46%), EAM Investors LLC (1.38%), Acadian Asset Management LLC (1.14%), Cadence Capital Management LLC (1.05%) and White Pine Capital LLC (0.66%). View institutional ownership trends for Electromed.

ELMD stock was sold by a variety of institutional investors in the last quarter, including Teton Advisors Inc., White Pine Capital LLC, and Carlson Capital Management. View insider buying and selling activity for Electromed.

ELMD stock was bought by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Cadence Capital Management LLC, Acadian Asset Management LLC, Navellier & Associates Inc, Cavalier Investments LLC, EAM Investors LLC, Wedge Capital Management L L P NC, and Advisor Group Holdings Inc.. View insider buying and selling activity for Electromed.

Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ELMD stock can currently be purchased for approximately $14.42.

Electromed has a market capitalization of $122.34 million. Electromed employs 132 workers across the globe.

The official website for Electromed is smartvest.com.

Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.